Fig. 2
From: Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
Naltrexone improves epithelial wound healing. a Expression of the μ-opioid receptor (MOR) was tested by rt-PCR, using -RT (i.e. RNA) controls. Ribosomal protein 2 (RP2) was used as cDNA quality control. b HCT116 (left panel) and CACO2 (right panel) cultures were scratched in the presence or absence of 1 μM Naltrexone (NTX), and wounds were photographed at t = 0, 24 and 48. Mean percentage wound size of three independent experiments is shown. c Migration of wound edges at t = 24 in pixels presented as mean of three experiments